XILIO THERAPEUTICS, INC.
Profile
Company Names
XILIO THERAPEUTICS, INC.
Addresses
828 WINTER STREET, WALTHAM, MA 02451
Phone Numbers
617-833-1027
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2020
State Incorporated:
DELAWARE
Total Amount Raised:
$145,249,979.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2021-02-23
$94,999,989.00
$94,999,989.00
$0.00
Equity
1
2021-01-20
$50,249,990.00
$50,249,990.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOSEPH
FARMER
EXECUTIVE OFFICER
DAVID
GARDNER
DIRECTOR
HOME PROPERTIES L P
| COFOUNDERS CAPITAL FUND I, LP
| REWARDSTOCK, INC.
| MEMENTO MORI, LLC
| SAVII, INC.
| PARKMYCLOUD, INC.
| MAP MY CUSTOMERS, INC.
| IMPATHIQ, INC.
| SERVUSCONNECT, INC.
| ACS ACQUISITIONS, INC.
| COFOUNDERS CAPITAL FUND II, LP
| FEEDTRAIL, INC.
| CARENEXIS, INC.
| DIGITAL LEADERSHIP GROWTH PATH, INC.
| THORNBURG INVESTMENT TRUST
| BN/AFIT, INC.
| ELEMENT451, INC.
| CITIZENS BANK GROUP INC.
| DOUBLE LOOP GAMES INC.
| XILIO THERAPEUTICS, INC.
| COFOUNDERS CAPITAL FUND I SIDECAR, LP
| AUTOMATION INTELLECT, INC.
| EMBRACER GROUP AB
| COFOUNDERS CAPITAL FUND III, LP
| BIOSPATIAL, INC.
| BRITE INC
| PEST SHARE, INC.
| CAPITAL ELEVEN VENTURE FUND II LP
| PETE INC.
| LEFT MAIN REI INC.
| LANDLORD TECH, INC.
| COFOUNDERS CAPITAL FUND IV, LP
| TEAM PROCURE, INC.
| NAVIGATE CAPITAL PARTNERS SBIC FUND II, LP
DAVID
GRAYZEL
DIRECTOR
ANNOVATION BIOPHARMA, INC.
| ARTEAUS THERAPEUTICS, LLC
| ATLAS VENTURE FUND XI, L.P.
| AKRIVEIA THERAPEUTICS, LLC
| ATLAS VENTURE OPPORTUNITY FUND I, L.P.
| AFFINIA THERAPEUTICS INC.
| ATLAS VENTURE FUND XII, L.P.
| AEROVATE THERAPEUTICS, INC.
| XILIO THERAPEUTICS, INC.
| SANTI THERAPEUTICS, INC.
| ATLAS VENTURE OPPORTUNITY FUND II, L.P.
| TRIANA BIOMEDICINES, INC.
| ATLAS VENTURE FUND XIII, L.P.
| COMANCHE BIOPHARMA CORP.
| ATLAS VENTURE FUND XIV, L.P.
ANDREW
HACK
DIRECTOR
NANCY
HONG
DIRECTOR
RACHEL
HUMPHREY
DIRECTOR
DANIEL
LYNCH
DIRECTOR
MICHAEL
ROSS
DIRECTOR
CERVILENZ INC
| JUVARIS BIO THERAPEUTICS INC
| IKANO THERAPEUTICS INC.
| ADIMAB, INC.
| SV LIFE SCIENCES FUND V LP
| LINK MEDICINE CORP
| CATABASIS PHARMACEUTICALS INC
| SV LIFE SCIENCES FUND V STRATEGIC PARTNERS, L.P.
| ARSANIS, INC.
| BALANCE HEALTH CORP
| ABCAM PLC
| ADIMAB, LLC
| AVITIDE, INC.
| OPHTHOTECH CORP.
| THESAN PHARMACEUTICALS, INC.
| SV LIFE SCIENCES FUND VI, L.P.
| DECIPHERA PHARMACEUTICALS, LLC
| DEMENTIA DISCOVERY LP
| AMERICLEAN HOLDINGS LLC
| SV LIFE SCIENCES FUND VI STRATEGIC PARTNERS, L.P.
| FRESCO FOODS, INC.
| SUTRO BIOPHARMA INC
| RIBOMETRIX, INC.
| JASON RYAN
| NICE RECOVERY SYSTEMS LLC
| THERINI BIO, INC.
| MAINE CRISP COMPANY, LLC
| JOSEPH VENTURES ALLIUM I LLC, SERIES A
| XILIO THERAPEUTICS, INC.
| JOSEPH VENTURES ALLIUM I LLC, SERIES C
| SV LIFE SCIENCES FUND IV CF, L.P.
| ANDOVIA INC.
| TREX HOLDINGS INC.
| DUALITAS THERAPEUTICS, INC.
RENE
RUSSO
EXECUTIVE OFFICER, DIRECTOR
ROBERT
WEISSKOFF
DIRECTOR
TETRAPHASE PHARMACEUTICALS INC
| ACCURI CYTOMETERS INC
| TRANSAVE INC
| IKANO THERAPEUTICS INC.
| ACORN CARDIOVASCULAR INC
| VIEWRAY INC
| BIOCONNECT SYSTEMS INC
| AMPHORA MEDICAL, INC.
| CARIBOU BIOSCIENCES, INC.
| IOWA APPROACH, INC.
| ZENFLOW, INC.
| TEMPEST THERAPEUTICS, INC.
| FARAPULSE, INC.
| CHECKMATE PHARMACEUTICALS, INC.
| AFFINIA THERAPEUTICS INC.
| XILIO THERAPEUTICS, INC.
| RARECYTE, INC.
| SHOUTI INC.
| BASECAMP BIO INC.
| ADELA, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

